Medicine & Life Sciences
von Willebrand Factor
100%
regadenoson
89%
Sickle Cell Anemia
67%
Natural Killer T-Cells
61%
Metalloproteases
55%
Thrombotic Thrombocytopenic Purpura
53%
Thrombospondin 1
43%
NKTT120
31%
ADAMTS13 Protein
29%
Krause-Kivlin syndrome
25%
Adenosine A2 Receptor Agonists
23%
ectonucleotide pyrophosphatase phosphodiesterase 1
22%
Disintegrins
22%
Cathepsin E
22%
B-Lymphocyte Differentiation Antigens
22%
Furin
21%
Thrombotic Microangiopathies
20%
Fucose
20%
Peptide Hydrolases
19%
Factor XI
18%
galactoside 2-alpha-L-fucosyltransferase
18%
Glycosylation
18%
Immunoglobulin Heavy Chains
16%
Organized Financing
15%
Hemophilia A
14%
Blood Platelets
14%
Differentiation Antigens
14%
Oligosaccharides
13%
Proteins
13%
Peptides
13%
Mutation
12%
Quality Control
12%
von Willebrand factor propolypeptide
12%
Glucosyltransferases
11%
Genetic Therapy
11%
Immunoglobulin M
11%
Thrombosis
11%
Cell Differentiation
10%
Disaccharides
9%
Endothelial Cells
9%
Monoclonal Antibodies
9%
Thrombospondins
8%
Enzymes
8%
Endoplasmic Reticulum
8%
Quality of Life
8%
Acquired Thrombotic thrombocytopenic purpura
7%
Phosphodiesterase I
6%
NF-kappa B
6%
Proteolysis
6%
eculizumab
6%
Chemical Compounds
Thrombotic
44%
Regadenoson
29%
Cleavage
26%
Plasma
24%
Adenosine A2 Receptor Agonist
23%
Mutation
21%
Oligosaccharide
20%
Protein
17%
Fucose
17%
Subcellular Localization
17%
Glycosylation
14%
Complementary DNA
13%
Peptide
12%
Quality Control
11%
Northern Blotting
10%
Disaccharide
9%
Lethal
9%
Serine
9%
Mannose
6%
Protein Hydrolysis
6%
Surface
6%
Heparin
6%
Epitope
6%
Trypsin
6%
Amino Acid Sequence
5%
Cofactor
5%
Amino-Acid Residue
5%
Fractionation
5%
Marker
5%
Label
5%
GDP-fucose
5%
Biosynthesis
5%